Clinical Trials for Non-small Cell Lung Cancer Stage IV

Find clinical trials for non-small cell lung cancer stage iv. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

NCT ID: NCT07104630

This clinical trial is studying whether pulmonary rehabilitation—a program of exercises and support to help with breathing—can improve the quality of life for people who have advanced non-small cel...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

NCT ID: NCT06463665

This clinical trial is exploring a new treatment approach for patients with advanced or metastatic non-small cell lung cancer (NSCLC), a type of lung cancer that has spread and is harder to treat. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States, Plantation, Florida, United States +10 more

A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

NCT ID: NCT06348199

This clinical trial is studying a new medication called SB27 to see if it works as well as an existing treatment called Keytruda for patients with stage IV non-squamous non-small cell lung cancer (...

Recruiting

Phase: PHASE3 Type: interventional Locations: Osaka, , Japan, Tokyo, , Japan +118 more

Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial

NCT ID: NCT06848426

This clinical trial is studying the effects of a traditional Chinese medicine called Xingbai Ji Formula when combined with standard chemotherapy and a drug called Sintilimab for patients with advan...

Not yet recruiting

Phase: NA Type: interventional Locations: Nanchang, Jiangxi, China

[177Lu]Lu-AKIR001 First-in-human Study

NCT ID: NCT06639191

This clinical trial is studying a new treatment called [177Lu]Lu-AKIR001 for patients with certain types of advanced cancers, such as thyroid cancer, head and neck cancer, and lung cancer, that can...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Stockholm, , Sweden

Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC

NCT ID: NCT06436144

This clinical trial is looking at a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) that has a specific genetic mutation called EGFR. While the standard treatme...

Not yet recruiting

Phase: PHASE2 Type: interventional

Intrathecal Double Checkpoint Inhibition

NCT ID: NCT05598853

This clinical trial is investigating a new treatment approach for patients with leptomeningeal metastasis, which is when cancer spreads to the membranes surrounding the brain and spinal cord. Speci...

Recruiting

Phase: PHASE1 Type: interventional Locations: Zurich, , Switzerland, Basel, , Switzerland +2 more

The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC

NCT ID: NCT06117644

This clinical trial is exploring the effectiveness of a double dose of Furmonertinib, a medication designed to treat non-small cell lung cancer (NSCLC) in patients who have developed resistance to ...

Not yet recruiting

Type: observational

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions